Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus

Qianfa Long,Dinesh Upadhya,Bharathi Hattiangady,Dong-Ki Kim,Su Yeon An,Bing Shuai,Darwin J Prockop,Ashok K Shetty,Darwin J. Prockop,Ashok K. Shetty
DOI: https://doi.org/10.1073/pnas.1703920114
IF: 11.1
2017-04-10
Proceedings of the National Academy of Sciences
Abstract:Significance This study demonstrated that intranasal (IN) administration of A1-exosomes alleviates multiple adverse changes that typically emerge after status epilepticus (SE), a medical crisis that presents a high propensity to evolve into chronic hippocampus dysfunction. Specifically, A1-exosome treatment after SE led to reduced neuron loss and inflammation, maintenance of normal neurogenesis, and preservation of cognitive and memory function. The results have significance for clinical application of A1-exosomes for curbing the evolution of SE-induced injury into chronic hippocampus dysfunction. The results also imply that IN administration of A1-exosomes is therapeutic for other neurological conditions that present with significant neuroinflammation.
multidisciplinary sciences
What problem does this paper attempt to address?